Enhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 867-872

  Westfall, T D ^a   Kennedy, C ^a   Sneddon, P ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

ARL 67156; ATP; Ecto ATPase; Purinergic transmission; Vas deferens

Indexed keywords

6 N,N DIETHYL BETA,GAMMA DIBROMOMETHYLENE ATP; ADENOSINE TRIPHOSPHATASE INHIBITOR; ADENOSINE TRIPHOSPHATE; BETA,GAMMA DIBROMOMETHYLENE 6 N,N DIETHYLADENOSINE TRIPHOSPHATE; NEUROTRANSMITTER; NORADRENALIN; POTASSIUM CHLORIDE; PRAZOSIN; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DEGRADATION; DOSE TIME EFFECT RELATION; GUINEA PIG; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE; VAS DEFERENS;

EID: 0029887568     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15273.x     Document Type: Article

References (32)

1. 2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Br. J. Pharmacol., 112, 219-225.
2. 2Y-purinoceptors. Br. J. Pharmacol., 113, 614-620.
3. BURNSTOCK, G. (1972). Purinergic nerves. Pharmacol. Rev., 24, 509-581.
4. BURNSTOCK, G. (1990). Purinergic mechanism. Annals. N. Y. Acad. Sci., 603, 1-17.
5. 2-purinoceptor? Gen. Pharmacol., 5, 433-440.
6. CRACK, B.E., POLLARD, C.E., BEUKERS, M.W., ROBERTS, S.M., HUNT, S.F., INGALL, A.H., MCKECHNIE, K.C.W., IJZERMAN, A.P. & LEFF, P. (1995). Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol., 114, 475-481.
7. CULIC, O., HUANG, Q.H., FLANAGAN, D., HIXSON, D. & LIN, S.H. (1992). Molecular cloning and expression of a new rat liver cell-CAM105 isoform. Biochem. J., 285, 47-53.
8. CUNNANE, T.C. & MANCHANDA, R. (1988). Electrophysiological analysis of the inactivation of sympathetic transmitter in the guinea-pig vas deferens. J. Physiol., 404, 349-364.
9. 1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens. Naunyn Schmied. Arch. Pharmacol., 350, 42-48.
10. 2+)-ATPase activity of the neural cell adhesion molecule. FEBS Lett., 336, 279-283.
11. EDLUND, M., GAARDSVOLL, H., BOCK, E. & ÖBRINK, B. (1993). Different isoforms and stock-specific variants of the cell adhesion molecule C-CAM (cell-CAM 105) in rat liver. Eur. J. Biochem., 213, 1109-1116.
12. GORDON, J. (1986). Extracellular ATP: effects, sources and fate. Biochem. J., 233, 309-319.
13. HARRIS, G.S. (1972). ATPase activity of pharmacological preparations. Eur. J. Pharmacol., 19, 137-139.
14. HOLCK, M.I. & MARKS, B.H. (1978). Purine nucleoside and nucleotide interactions on normal and subsensitive alpha adrenoceptor responsiveness in guinea-pig vas deferens. J. Pharmacol. Exp. Ther., 205, 104-117.
15. KATSURAGI, T., TOKUNAGA, T., OGAWA, S., OSAMU, S., CHIEMI, S. & FURUKAWA, T. (1991). Existence of ATP-evoked ATP release system in smooth muscles. J. Pharmacol. Exp. Ther., 259, 513-518.
16. KAZIC, T. & MILOSAVLJEVIC, D. (1980). Interaction between adenosine triphosphate and noradrenaline in the isolated vas deferens of the guinea-pig. Br. J. Pharmacol., 71, 93-98.
17. 2x-purinoceptors be characterised pharmacologically? Trends Pharmacol. Sci., 16, 168-174.
18. 2-purinoceptor antagonists. Br. J. Pharmacol., 115, 2P.
19. LIN, S.H. & GUIDOTTI, G. (1989). Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. J. Biol. Chem., 264, 1408-1414.
20. MCCUAIG, K., ROSENBERG, M., NEDELLEC, P., TURBIDE, C. & BEAUCHEMIN, N. (1993). Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. Gene, 127, 173-183.
21. 2x-purinoceptor antagonist, in the guinea-pig isolated vas deferens. Br. J. Pharmacol., 111, 913-917.
22. NAJJAR, S.M., ACCILI, D., PHILLIPE, N., JERNBERG, J., MARGOLIS, R. & TAYLOR, S.I. (1993). pp120/ecto-ATPase, an endogenous substrate of the insulin receptor tyrosine kinase, is expressed as two variably spliced isoforms. J. Biol. Chem., 268, 1201-1206.
23. O'CONNOR, S.E., DAINTY, I. & LEFF, P. (1991). Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sci., 12, 137-141.
24. SAKAI, K.K., HYMSON, D.L. & SHAPIRO, R. (1979). The effects of adenosine and adenine nucleotides in the guinea-pig vas deferens: evidence for existence of purinergic receptors. Life Sci., 24, 1299-1308.
25. 1-purinoceptors. Eur. J. Pharmacol., 105, 293-299.
26. SNEDDON, P., WALKER, H.P., LEFF, P. & KENNEDY, C. (1995). Enhancement of sympathetic, purinergic neurotransmission by a novel ecto-ATPase inhibitor in guinea-pig isolated vas deferens. Br. J. Pharmacol., 115, 109P.
27. SNEDDON, P. & WESTFALL, D.P. (1984). Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J. Physiol., 347, 561-580.
28. SNEDDON, P., WESTFALL, D.P. & FEDAN, J.S. (1982). Cotransmitters in the motor nerves of the guinea-pig vas deferens: electrophysiological evidence. Science, 218, 693-695.
29. SOMLYO, A.P. & SOMLYO, A.V. (1994). Signal tranuction and regulation in smooth muscle. Nature, 372, 231-236.
30. VIZI, E.S., SPERLAGH, B. & BARANYI, M. (1992). Evidence that ATP, released from the postsynaptic site by noradrenaline, is involved in mechanical responses of guinea-pig vas deferens: cascade transmission. Neurosci., 50, 455-465.
31. WALSH, M.P. (1994). Regulation of vascular smooth muscle tone. Can. J. Physiol. Pharmacol., 72, 919-936.
32. ZIGANSHIN, A.U., HOYLE, C.H.V. & BURNSTOCK, G. (1994). Ectoenzymes and metabolism of extracellular ATP. Drug Dev. Res., 32, 134-146.